We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




POC Diagnostic Kits Targeted for Resource-Limited Areas

By LabMedica International staff writers
Posted on 24 Mar 2011
A biotechnology company intends to develop new point of care (POC) diagnostic technologies, which are targeted for use in resource-limited settings.

The technologies will be geared toward the development of noninvasive, urine-based, rapid detection systems for the diagnosis of a panel of sexually transmitted infections, in addition to other diseases such as Tuberculosis.

The company, Norgen Biotek (Thorold, ON, Canada) received over US$800,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP; Ottawa, ON, Canada).

The company focuses primarily on advancing powerful tools for nucleic acids (NA) and protein purification and preservation, as well as developing leading-edge diagnostic tools.

With the new funding Norgen will focus on the development of POC human diagnostic kits for use in resource-limited areas, as well as for home use testing. More...
The new technologies will rely on the use of noninvasive specimens such as urine and saliva for ease of use and cost reduction. Norgen's purification technology is extremely well suited for use in resource-limited settings, as Norgen's resin is able to isolate and concentrate DNA, RNA, and proteins from samples without the use of centrifugation or other equipment.

Norgen has developed technologies and products for the purification of nucleic acids and proteins on both preparative and industrial scales, including ready-to-use chromatography resins and prepacked chromatography columns.

Related Links:

Norgen Biotek
National Research Council of Canada Industrial Research Assistance Program



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.